Dichotomous outcomes vs. survival regression models for identification of predictors of mortality among patients with severe acute respiratory illness during COVID-19 pandemicsPublic Health Original Research Published on 2023-12-062024-09-05 Journal: Frontiers in public health [Category] update2024, [키워드] Clinical predictors COVID-19 Cox regression Multivariable models Poisson regression SARI [DOI] 10.3389/fpubh.2023.1271177 PMC 바로가기 [Article Type] Public Health Original Research
Dispositional optimism and all-cause mortality after esophageal cancer surgery: a nationwide population-based cohort studyArticle Published on 2022-11-012022-11-15 Journal: Supportive Care in Cancer [Category] 진단, [키워드] 95% CI all-cause mortality Assessing association Cancer Cohort confounder COVID-19 COVID-19 pandemic Cox regression death esophagectomy Follow-up help IMPROVE increase in Increasing information Intervention life median occurred optimism Orientation Patient patients patients died Population population-based cohort Positive psychology postoperative predict prospective cohort study risk survival survivorship Swedish Total tumor stage was measured was obtained was used [DOI] 10.1007/s00520-022-07311-z PMC 바로가기
Outcomes following SARS-CoV-2 infection in individuals with and without solid organ transplantation-A Danish nationwide cohort studyArticle Published on 2022-11-012022-11-16 Journal: American journal of transplantation : official jou [Category] COVID19(2023년), SARS, 변종, [키워드] 95%CI acute respiratory syndrome Analysis assisted respiration calculate clinical research/practice Cohort cohort study comparable Contact coronavirus Cox regression death Effect General population hospital Hospitalization incidence rate increased risk increased the risk individual Infection infection and infectious agents - viral infection and infectious agents - viral: SARS-CoV-2/COVID-19 infectious agent Infectious disease lower risk Mortality omicron organ performed recipient reduce reduced risk SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccine SARS-CoV2 infection severe COVID-19 solid organ transplant solid organ transplantation vaccination Vaccinations variant were used with COVID-19 [DOI] 10.1111/ajt.17142 PMC 바로가기
Observational study of factors associated with morbidity and mortality from COVID-19 in Lebanon, 2020-2021Article Published on 2022-10-192022-11-15 Journal: PLoS ONE [Category] COVID19(2023년), SARS, 바이오마커, [키워드] acute kidney Admission age Analysis association Biomarker Blood Care Chronic kidney disease claimed COVID-19 COVID-19 pandemic COVID-19 patient Cox regression creatinine defined develop diabete disease effort elevated etiology evaluated Factor fatality favor Gender high mortality highest hospitalized patients independent risk factor intubation investigated Kidney function Kidney injury management morbidity morbidity and mortality Mortality observational study outcomes Patient patients performed Regression SARS-CoV-2 serum serum creatinine severe disease Shortness of breath shown significantly the disease time vaccination variable vital sign [DOI] 10.1371/journal.pone.0275101 PMC 바로가기
Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational studyArticle Published on 2022-10-082022-11-15 Journal: Lancet (London, England) [Category] COVID19(2023년), SARS, 변종, 치료제, [키워드] Abstract Admission age ambulatory patient Analysis Antiviral antiviral drug authority B.1.1.529 Case-control Charlson Comorbidity Index China Chinese clinical effectiveness Cohort Community Control COVID-19 outpatient Cox regression death Diagnosis diagnosis of SARS-CoV-2 Disease progression dominant Effectiveness glomerular filtration rate hazard Hong Kong hospitalisation HRs identify in both group In-hospital In-hospital death Infection intensive care Invasive mechanical ventilation less Logistic regression lower risk material median molnupiravir Mortality Nirmatrelvir non-hospitalised Odds ratio Older older patients outcome Outpatient Patient patients with COVID-19 primary analysis reduced risk Region Registered retrospective cohort risk Ritonavir SARS-CoV-2 SARS-COV-2 infection sensitivity analysis Sex supported the SARS-CoV-2 translation used data vaccination variant [DOI] 10.1016/S0140-6736(22)01586-0 PMC 바로가기
Risk factors associated with hospitalization in patients with asymptomatic or mild COVID-19 in public accommodation facilities in TokyoObservational Study Published on 2022-10-012022-10-04 Journal: Journal of infection and chemotherapy : official j [Category] COVID19(2023년), SARS, 임상, [키워드] Admission age association Care conducted coronavirus disease COVID-19 COVID-19 patient Cox regression Cox regression analysis Cox regression model diabetes epidemiological data evaluated Factor Fever Gout groups hazard ratio high risk Hospitalization Hospitalized hospitalized patient Japan medical intervention medication Mild obesity Observational cohort study Oxygen administration Patient patients with asymptomatic patients with COVID-19 provided psychiatric disease Psychiatric medication Recovery accommodation facility. required risk factor sensitivity analysis severe respiratory symptoms significantly higher Symptom the median Tokyo underlying disease [DOI] 10.1016/j.jiac.2022.06.002 PMC 바로가기 [Article Type] Observational Study
Outcome of SARS-CoV-2 infection among patients with common variable immunodeficiency and a matched control group: A Danish nationwide cohort studyArticle Published on 2022-09-232022-11-16 Journal: Frontiers in Immunology [Category] SARS, 치료기술, [키워드] age calculate Clinical outcome cohort study common variable immunodeficiency (CVID) conducted Contact control group Coronavirus-2 Course COVID-19 Cox regression CVID death detectable estimate Gender General population groups hospital Immunity immunodeficiency in both groups inborn errors of immunity (IEI) incidence rate increased risk individual Infection mechanical ventilation not differ Novel coronavirus outcome Patient Re-infection risk Sample size SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccination severe adult respiratory coronavirus-2 (SARS-CoV-2) severe novel coronavirus 2019 (COVID-19). severity the timing was used [DOI] 10.3389/fimmu.2022.994253 PMC 바로가기
Fibrosis-4 (FIB-4) Index and mortality in COVID-19 patients admitted to the emergency departmentArticle Published on 2022-09-012022-11-15 Journal: Internal and Emergency Medicine [Category] 바이오마커, [키워드] 95% CI 95% confidence interval adjusted hazard ratio ALT Analysis AST AUC cohort study coronavirus COVID-19 COVID-19 patient Cox regression cut-off Department disease Emergency Endpoint FIB-4 fibrosis Fibrosis-4 High-flow oxygen identify increased mortality index Liver damage Liver fibrosis liver transaminase log-rank test mechanical ventilation Mortality mortality risk Patient performed predict Predictive Prognosis ROC analysis ROC Curve secondary to define were used worse prognosis [DOI] 10.1007/s11739-022-02997-9 PMC 바로가기
Efficacy and safety of camostat mesylate in early COVID-19 disease in an ambulatory setting: a randomized placebo-controlled phase II trialClinical Trial Published on 2022-09-012022-10-04 Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), SARS, 임상, 치료제, [키워드] 95% confidence interval adverse event Analysis antiviral drug assigned asymptomatic patient camostat Camostat mesylate Clinical improvement conducted Confirmed COVID-19 infection COVID-19 COVID-19 disease Cox regression cycle threshold distribution early phase effective Efficacy Efficacy and safety Frequency hazard ratio nasopharyngeal viral load Neutralizing antibodies Neutralizing antibody titer participant performed Placebo placebo group placebo-controlled protocol Randomized Randomized controlled trial Randomly receive Safety SARS-CoV-2 symptomatic treat Treatment Trial two groups [DOI] 10.1016/j.ijid.2022.06.054 PMC 바로가기 [Article Type] Clinical Trial
J-shaped associations and joint effects of fasting glucose with inflammation and cytokines on COVID-19 mortalityResearch article Published on 2022-09-012022-10-05 Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), SARS, 바이오마커, [키워드] Admission association C-reactive protein Coagulation Combination COVID-19 COVID-19 mortality Cox regression cytokine Cytokines death demonstrated discharge Dose-response Effect evaluate Fasting blood glucose fasting glucose higher risk hospital Hospitalized hospitalized patient hyperglycemia Inflammation intensive care Interaction interleukin-6 intubation joint Joint Effects lactate dehydrogenase marker Mortality objective outcome outcomes Patient procalcitonin proportion reached Result Retrospective study spline union Virus Disease with COVID-19 women Wuhan [DOI] 10.1016/j.ijid.2022.05.060 [Article Type] Research article